Entering text into the input field will update the search result below

Nevro: A Top Recovery Play As Covid Abates

Jan. 03, 2022 8:39 PM ETNevro Corp. (NVRO)5 Comments
Out of Ignorance profile picture
Out of Ignorance


  • The pandemic has raked Nevro over the coals these last few years.
  • There are signs that the pandemic may finally be winding down.
  • Once pandemic and PDN launch preliminaries are behind it, Nevro will have enormous growth potential as it develops this first to market indication.

Freedom concept

Boonyachoat/iStock via Getty Images

Nevro (NYSE:NVRO) is the leading pure play operator in spinal cord stimulation [SCS]. It contends in this SCS market against giants like Abbott Laboratories (ABT), Medtronic (MDT), and Boston Scientific (

This article was written by

Out of Ignorance profile picture
Writing under the pseudonym "out of ignorance", I very much regard investing as a learning process. Investing failures are tuition paid. Investing successes enter the trove of lessons learned. In my Seeking Alpha articles I share my experience from decades of investing and from ~5 years of focused research on a variety of stocks, in recent years with a primary emphasis on healthcare stocks. I greatly appreciate those who take the time to share their reactions to articles, particularly those who share relevant anecdotes and experiences.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABT AND GILD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I may buy or sell interests in any company mentioned over the next 72 hours.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.